These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8891614)
1. Differential effects of five glycine site antagonists on NMDA receptor desensitisation. Molnár P; Erdõ SL Eur J Pharmacol; 1996 Sep; 311(2-3):311-4. PubMed ID: 8891614 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist. Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205 [TBL] [Abstract][Full Text] [Related]
3. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro. Boireau A; Malgouris C; Burgevin MC; Pény C; Durand G; Bordier F; Meunier M; Miquet JM; Daniel M; Chevet T; Jimonet P; Mignani S; Blanchard JC; Doble A Eur J Pharmacol; 1996 Apr; 300(3):237-46. PubMed ID: 8739214 [TBL] [Abstract][Full Text] [Related]
5. Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones. Wang LY; MacDonald JF J Physiol; 1995 Jul; 486 ( Pt 1)(Pt 1):83-95. PubMed ID: 7562646 [TBL] [Abstract][Full Text] [Related]
6. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons. Jarvis CR; Xiong ZG; Plant JR; Churchill D; Lu WY; MacVicar BA; MacDonald JF J Neurophysiol; 1997 Nov; 78(5):2363-71. PubMed ID: 9356388 [TBL] [Abstract][Full Text] [Related]
7. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain. Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor. Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of NMDA receptor glycine recognition site antagonism: dependence on glycine concentration. Pearlstein RD; Beirne JP; Massey GW; Warner DS J Neurochem; 1998 May; 70(5):2012-9. PubMed ID: 9572287 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324. Priestley T; Laughton P; Macaulay AJ; Hill RG; Kemp JA Neuropharmacology; 1996; 35(11):1573-81. PubMed ID: 9025105 [TBL] [Abstract][Full Text] [Related]
11. Estimation of the relative potency of two glycine antagonists on NMDA-induced depolarizations in BRSC and ARCS. Corsi M; Bettelini L; Fina P; Trist DG Ann N Y Acad Sci; 1997 May; 812():187-8. PubMed ID: 9186738 [No Abstract] [Full Text] [Related]
12. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons. Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478 [TBL] [Abstract][Full Text] [Related]
13. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583 [TBL] [Abstract][Full Text] [Related]
14. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors. Kleckner NW; Dingledine R Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776 [TBL] [Abstract][Full Text] [Related]
15. Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons. Marchioro M; Swanson KL; Aracava Y; Albuquerque EX J Pharmacol Exp Ther; 1996 Oct; 279(1):143-53. PubMed ID: 8858987 [TBL] [Abstract][Full Text] [Related]
16. Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons. Fontana G; Valenti L; Raiteri M J Neurosci Res; 1997 Sep; 49(6):732-8. PubMed ID: 9335260 [TBL] [Abstract][Full Text] [Related]
18. Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor. Lingenhöhl K; Pozza MF Neuropharmacology; 1998 Jun; 37(6):729-37. PubMed ID: 9707286 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site. Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676 [TBL] [Abstract][Full Text] [Related]
20. Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons. Kemp JA; Priestley T Mol Pharmacol; 1991 May; 39(5):666-70. PubMed ID: 1674587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]